BioSpace News Archive

Abiomed, Inc., a leading provider of breakthrough heart support technologies reported fourth quarter fiscal 2020 revenue of $206.7 million compared to revenue of $207.1 million for the same period of fiscal 2019.

Transparency Market Research has published a new report on the gonorrhea therapeutics market for the forecast period of 2019–2027.

Transparency Market Research has published a new report on the cough hypersensitivity syndrome treatment market for the forecast period of 2019–2027.

Some prescription medicines are controlled under the Misuse of Drugs legislation. These medicines are called controlled substances or controlled drugs. Doctors can prescribe all controlled medicines to treat an illness or injury.

Transparency Market Research has published a new report on the biological imaging reagents market for the forecast period of 2019–2027.

According to the World Health Organization, Pharmacovigilance is the activities and science about the prevention, understanding, assessment, and detention of adverse effects or any other problem related to drugs.

Transparency Market Research has published a new report on the amniotic membrane market for the forecast period of 2019-2027.

ILC Dover, a world leader in the innovative design and production of engineered products employing high-performance flexible materials, announced that it expedited the regulatory approval and manufacturing processes of a new Powered Air Purifying Respirator hood for healthcare workers attending to patients with COVID-19.

Free service builds on the company’s commitment to making it easier for HCPs to engage the precise life sciences expertise, information, and resources they need [30-April-2020] LOS ANGELES , April 30, 2020 /PRNewswire/ -- RxVantage , the digital education platform that makes it easy for practices to engage with life science companies, today announced the launch of Rx

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system disorders, announced that it will report its financial results for the first quarter of 2020 on Friday, May 8, 2020 before the opening of the U.S. financial markets.